ANIP's first-quarter 2025 revenues are likely to have been driven by increased sales of its lead pro...
ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look...
ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 12-Month High - Should You Buy?...
Demonstrated Dose Dependent Effect in EAU Presented in a podium presentation at The Association for ...